Atovaquone Molecular Chemical Structure.jpg (Atovaquone Proguanil Spl Graphic 01)
Atovaquone And Proguanil Hcl Tablet, Film Coated
Product Images NDC 66993-060
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone And Proguanil Hcl (NDC 66993-060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Proguanil Hydrochloride Molecular Chemical Structure.jpg (Atovaquone Proguanil Spl Graphic 02)
100 Tablet Bottle Label (Atovaquone Proguanil Spl Graphic 03)
Atovaquone and Proguanil HCl Tablets, NDC 66993-060-02, come in 100-tablet bottles, and each tablet contains 250 mg atovaquone and 100 mg proguanil HCl. It is essential to read the accompanying prescription data for dosing and administration. The tablets should be stored at 25°C, with no more than 15° to 30°C temperature excursions during shipment. Do not use if the protected seal beneath the cap is damaged or absent. Prasco Laboratories is the producer, and GlaxoSmithKline manufactures the medication. Made in Canada. This information is valid as of June 2017.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
